The university of tennessee experience with the indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: Interim analysis

World Journal of Urology

Volumn 16, Issue 6, 1998, Pages 386-391

  Greenberger, Mark ^a   Steiner, Mitchell S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; HUMAN; INSTRUMENTATION; LASER COAGULATION; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PATIENT SATISFACTION; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUESTIONNAIRE; SAFETY; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SAFETY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TENNESSEE; TREATMENT OUTCOME;

EID: 0032248303     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050087     Document Type: Article

References (30)

1. Arai Y. Ishitoya S, Okubo K, Suzuki Y (1995) Interstitial laser coagulation for benign prostatic hyperplasia: treatment outcome and quality of life (QOL). J Urol 153: 415A
2. Cammack JT, Motamedi M, Torres JH, Orihuela E. Cowan D, Warren MM (1993) Endoscopie Nd:YAG laser coagulation of the prostate: comparison of lower power versus high power (abstract). J Urol 149: 2ISA
3. Childs SJ (1994) Ablation of prostate tissue at high power density. In: Watson GM, Steiner RW, Johnson DE (eds) Lasers in urology. SPIE proceedings, vol 2129. Bellingham, Washington, pp 8-! 4
4. Cowles RS, Kabalin JN. Childs S, Lepor H, Dixon C, Stein B, Zabbo A (1995) A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 46: 155-161
5. De la Rosette JJMCH. Froeling FMJA, Alivizatos G, Debruyne FMJ (1994) Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur Urol 25: 19-24
6. Dixon C (1995) Lasers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 22: 413-422
7. Dixon C, Machi G. Theurne C, Lepor H (1993) A prospective, double-blind, randomized study comparing laser ablation of the prostate and transurethral prostatectomy for the treatment of BPH (abstract). J Urol 149: 215A
8. Doll HA, Black NA. McPherson K, Flood AB, Williams GB, Smith JC (1992) Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol 147: 1566-1573
9. Gottfried HW, Frohneberg D, Rosette JJMCH de la. Lawrence W, Hautmann RE (1995) Transurethral laser ablation of prostate (TULAP). Experience of a European multicenter study using ultraline fiber (abstract). J Urol 153: 230A
10. Holtgrewe LH (1995) Transurethral prostatectomy. Urol Clin North Am 22: 357-368
11. Hvidt V, Eidraup J (1994) Comparison of patients undergoing transurethral resection of the prostate in 1935-36 and 1991-92. Scand J Urol Nephrol [Suppl] 157: 129-132
12. Kabalin JN ( 1993) Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting. J Urol 150: 95-99
13. McConnell J, Barry M, Bruskewitz RC (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline Number 8. AHCPR Publication 94-0582. Public Health Service, US DHHS, Rockville, Maryland
14. Mebust WK (1989) A review of TURP complications and the AVA National Cooperative study. AVA update series 8: 186
15. Mesbut W, Hotlgrewe L, Cocket A, et al (1989) Transurethral prostatectomy: evaluation of 3885 patients. J Urol 141: 243
16. Mueller-Lisse UG, Heuck AF, Schneede P, et al (1996) Postoperative M RI in patients undergoing interstitial laser coagulation thermotherapy of benign prostatic hyperplasia. J Comput Assist Tomogr 20: 273
17. Muschter R. Hofstetter A (1995) Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 9: 129-135
18. Muschter R, Hofstetter A (1995) Technique and results of interstitial laser coagulation. World J Urol 13: 109-114
19. Muschter R. Perlmutter AP (1994) The optimization of laser prostatectomy. II. Other lasing techniques. Urology 44: 856-861
20. Muschter R, Hessel S, Hofstetter A, Keiditsch E. Rothenbcrger K-H, Schneede P, Frand F (1993) Die interstitielle Laserkoagulation der benignen prostatahyperplasie. Urologe [A] 32: 273-281
21. Muschter R. Rosette JJMCH de la, Whitfield H, et al (1996) Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 48: 223
22. Narayan P, Tewari A, Fournier G, Toke A (1995) Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia. Urology 45: 776-782
23. Neal DE (1994) Evaluation and results of treatment for prostatism. Urol Res 22: 61-66
24. Perlmutter AP. Muschter R (1994) The optimization of laser prostatectomy. I. Free beam side fire coagulation. Urology 44: 847-855
25. Shanberg AM, Lee IS, Tansey LA, Sawyer DE (1994) Extensive neodymium-YAG photo irradiation of the prostate in men with obstructive prostatism. Urology 43: 467-471
26. Thorpe AC, Cleary R, Coles J, Vernon S. Reynolds J, Neal DE (1994) Deaths and complications following prostatectomy in the northern region of England. Br J Urol 74: 559-565
27. Walsh PC (1992) Benign prostatic hyperplasia. In: Walsh PC. Retik AB, Stamey TA, Vaughan ED Jr (eds) Campbell's urology. 6th edn, vol 3. W.B Saunders, Philadelphia, pp 1009-1027
28. Wasson JH, Reda DJ. Bruskewitz RC, Elinson J. Keller AM. Henderson WG (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 332: 75-79
29. Watson G (1995) Contact laser prostatectomy. World J Urol 13: 115-118
30. Whitfield HN, Meganathan V (1996) Interstitial diode laser (Indigo) in BPH: a randomized, controlled, prospective study. Eur Urol 30 [Suppl 2]: 261